ARCHIVES

Telatinib Demonstrates Positive Results in First-Line Treatment

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

Sen. Dole Raps HEW Over Delays On Patent Requests

August 11, 1978

Hamburg Confirmed As FDA Commissioner

May 22, 2009

White House Yet To Name NCAB, Cancer Panel Members

February 11, 2011

Investigators Testing Ways To Overcome Gleevec Resistance: High Dose, New Drugs

January 28, 2005

In Brief: FDA Oncology Div. Director Burke To Leave; Reed Is Branch Chief; NCAB Blasts Tobacco

November 4, 1994

ACS Board allocated $37.5 Million to Research; More Coming

February 20, 1987